Cartalax 20mg is a short-chain bioregulator peptide supplied by Peptide Sciences for research into cartilage and connective tissue. Each 20mg vial is lyophilised and tested by HPLC and mass spectrometry before release.
Cartalax and Cartilage Research
Bioregulator peptides are di-, tri- and tetrapeptides developed from research by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. The hypothesis is that these short sequences can enter cells and interact with DNA or chromatin to influence gene expression in specific tissues. Cartalax (Ala-Glu-Asp) is associated with cartilage and is studied for its influence on chondrocyte function and connective-tissue ageing in experimental models.
Cartalax 20mg Specifications
| Property | Value |
|---|---|
| Compound | Cartalax |
| Class | Khavinson short-peptide bioregulator |
| Source-tissue derivation | Cartilage tissue fraction |
| Supplied form | Lyophilised powder, sealed vial |
| Strength | 20 mg per vial |
| Purity | greater than 99 percent (HPLC verified) |
| Storage | 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term |
Using the Cartalax 20mg Vial
A 20mg vial supports multi-week cell-culture or animal protocols from one lot. Researchers often compare Cartalax with other tissue-specific bioregulators in our catalog to study how tiny sequence differences change tissue targeting.
Quality Control, COA and Shipping
Our release testing covers purity (HPLC), identity (MS) and appearance for every production lot. Orders include the lot-matched COA and leave our US warehouse in insulated, tamper-evident packaging to keep research material stable.
Related Research Compounds
Researchers working with Cartalax often compare results with these catalog compounds:
- Chonluten 20mg (Bioregulator)
- Vesugen 20mg (Bioregulator)
- TB-500 (Thymosin Beta-4) 5mg (43aa)
- Testagen 20mg (Bioregulator)
Explore the full Bioregulator Peptides collection, browse the complete Peptide Sciences research peptide catalog, or review published literature on Cartalax in PubMed.
Research use only. This product is sold strictly for in-vitro laboratory research and development by qualified professionals. It is not for human or veterinary use, not a drug, food or cosmetic, and has not been evaluated by the FDA to diagnose, treat, cure or prevent any disease. Buyers must be 21+ and comply with all applicable laws.
Reviews
There are no reviews yet.